NOV 18, 2021
Comprehensive Ophthalmology, Diagnostic & Screening, Pediatric Ophth/Strabismus
0.5 General AMA PRA Category 1 Credits™
Drs. Pavlina Kemp and Matthew Weed offer clinical pearls on current options for preventing myopia progression, ranging from topical therapy with atropine to orthokeratology to lifestyle or environmental measures.
Release: November 18, 2021; expires November 18, 2024
Planner/Faculty: Dr. Sridhar reports no relevant financial disclosures.
Faculty: Drs. Kemp and Weed report no financial disclosures.
Reviewer: Jeffrey D. Henderer, MD, reports no financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of myopia or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this internet enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.